A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects
Clinical trial NCT02039076 · COMPLETED
Trial details
- NCT number
- NCT02039076
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2014-06-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.